Avg closing price
Price range

3 Stanley Druckenmiller Recursion Pharmaceuticals Trades

Stanley Druckenmiller acquired 1.39 Million Recursion Pharmaceuticals shares worth $12.2 Million. That's 0.47% of their equity portfolio (27th largest holding). The investor's estimated purchase price is $18.8 Million, resulting in a loss of 35%.

Avg closing price
Price range
Increased shares by 406.5% (+1.11 Million shares) Q3 2022
Avg closing price $10.13
Price range $7.83 - $13.60
Increased shares by 5.3% (+13.7 Thousand shares) Q1 2022
Avg closing price $10.63
Price range $6.16 - $18.03
New holding (+260 Thousand shares) Q3 2021
Avg closing price $28.34
Price range $19.03 - $41.33

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!